When the historical maximum was achieved on 20 December, Pfizer stocks reversed downwards and moved to the downtrend. Public concern on the spread of the coronavirus has paled into insignificance as more attractive objects for investment have appeared.
The downtrend of the historical maximum has led Pfizer to the two November gaps at 46 and 44.4. The first gap was successfully closed followed by an attempt to the upward bounce. The RSI reversed upwards from the oversold zone but so far this is the only factor in favor of a rise.
While the price has not overcome the downward trend, another attempt to close the gap at 44.4 is probable.